Kaleido Biosciences Q2 EPS $(0.56) Up From $(0.59) YoY
Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.56) per share. This is a 5.08 percent increase over losses of $(0.59) per share from the same period last year.
Related Posts
13 Analysts Have This to Say About CME Group
CME Group (NASDAQ:CME) has observed the following analyst ratings within the last quarter:
General Mills Shares Drop Premarket After Company Flags Inflation Worries For FY22
General Mills Inc (NYSE:GIS) reported fourth-quarter FY21 sales of $4.5 billion, down 10% year-on-year, beating the consensus estimate of $4.36 billion.…
Canopy Growth CEO To Deliver Keynote Presentation At Benzinga’s Cannabis Capital Conference Apr. 20, 2022
Benzinga, a financial news and data company recently acquired at a$300 million valuation, announced that the CEO of Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED)